RNVU1-26

Across TCGA pan-cancer cohorts, RNVU1-26 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNVU1-26 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNVU1-26 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNVU1-26 expression acts as an unfavorable survival marker, although some lineages such as SARC show a favorable association.

THCA, ACC, and LAML are the cancer types where RNVU1-26 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.962	0.993	<.001	96	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	51	view →
LAML	DFS	Tertile	All	0.298	0.521	.019	34	view →
ESCA	DFS	Tertile	All	0.306	0.567	<.001	18	view →
COAD	DFS	Tertile	II,III,IV	0.170	0.776	.005	18	view →
LIHC	OS	Tertile	All	0.537	0.697	.022	15	view →
LUAD	OS	Tertile	III,IV	0.276	0.547	.029	12	view →
SARC	DFS	Tertile	All	0.522	0.311	.036	12	view →
DLBC	OS	Quartile	II,III,IV	0.640	1.000	.031	5	view →
THYM	DFS	Tertile	All	0.774	0.927	.021	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNVU1-26–THCA (OS)

Open the THCA breakdown →